Oxygenta Pharmaceutical Ltd — Important, 12-01-2026: Company Update

Oxygenta Pharmaceutical has confirmed its adherence to share dematerialization compliance for the quarter ended December 31, 2025. The company's Registrar and Share Transfer Agent (RTA) verified and processed physical shares received for dematerialization, ensuring they were cancelled and electronic records updated with depositories (NSDL and CDSL) within the required 15-day timeframe. This ensures accurate and timely record-keeping for investors, reflecting the company's commitment to maintaining efficient share administration and compliance with market operational standards.